Best Practice Case Studies-Care of the Transgender Athlet LH

Video Transcription

Video Summary

The lecture by Dr. Kate Ackerman focused on the care of transgender athletes, highlighting the complexities surrounding hormonal treatments, policies, and inclusion in sports. Dr. Ackerman discussed key differences between biological sex and gender identity, emphasizing the nuanced processes of gender transition and the important role of ongoing research in informing sports policies. She reviewed current data on how gender-affirming hormone therapy affects body composition and athletic performance, noting that although trans women experience reductions in lean body mass and strength, disparities with cis women remain. Dr. Ackerman stressed the need for more research, particularly prospective studies on transgender youth athletes, to understand the impacts of early treatments. She also covered therapeutic use exemptions necessary for athletes undergoing hormone therapy, as well as the varying policies and requirements set by sports organizations. Dr. Ackerman encouraged approaching the topic with an open mind and kindness, focusing on inclusivity and understanding that these athletes are individuals with unique experiences. This emphasis on humanity and respect was echoed in the Q&A session, where questions about team support for transgender athletes and long-term effects of hormone therapies were addressed.

Meta Tag

Concept Biological Sex

Concept Gender

Concept Transgender Identity

Concept Gender-Affirming Hormone Therapy

Concept Differences in Sexual Development

Edition 3rd Edition

Related Case 3rd Edition, CASE 19

Topic Gender Issues

Keywords

3rd Edition, CASE 19

3rd Edition

Gender Issues

transgender athletes

hormonal treatments

sports policies

gender identity

gender transition

hormone therapy

inclusivity

therapeutic use exemptions

athletic performance

Biological Sex

Gender

Transgender Identity

Gender-Affirming Hormone Therapy

Differences in Sexual Development